Drug Type Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism SSTR2 modulators(Somatostatin receptor 2 modulators), Ionising radiation emitters |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 2 | CN | 01 Jun 2022 | |
SSTR2 positive Gastro-Enteropancreatic Neuroendocrine Tumor | Phase 1 | CN | 28 Aug 2024 |